PAIN
Volume 139, Issue 2 , Pages 477-479, 15 October 2008

Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors

Nuffield Department of Anaesthetics, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK

Received 18 June 2008; accepted 28 July 2008. published online 15 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3959(08)00423-5

doi:10.1016/j.pain.2008.07.026

Refers to article:

  • Role of placebo factors in clinical trials with special focus on enrichment designs , 15 September 2008

    Roland Staud, Donald D. Price
    PAIN 15 October 2008 (Vol. 139, Issue 2, Pages 479-480)

PAIN
Volume 139, Issue 2 , Pages 477-479, 15 October 2008

Article Tools